October / November 2010 At the End of Your Rope? by Tim Murphy Ironically, the success of today’s antiretroviral treatments has hindered the development of new options for longtime survivors with drug-resistant HIV. Chad Kenney, 56, was always aggressive when it came to his HIV treatment. Shortly after his 1987 diagnosis, the Denver native started […]
At the End of Your Rope? Read More »
Today was the start of the first international workshop on Aging and HIV in Baltimore. The program was started by Dr L. Ferrucci who gave the first presentation on frailty. He works in geriatrics and presented general data from previous studies in the general aging HIV negative population. He presented compelling data that showed that
Report from the Aging and HIV Workshop- Frailty Read More »
I will start blogging tomorrow from this new workshop. I am glad we will be able to discuss the issues related to the seemingly accelerated aging that some long term survivors are experiencing. Tomorrow we will be listening to presenters speaking about frailty, immunology of aging, immunosenescense, neurocognitive changes, bone loss, vitamin D deficiency and
Blogging from the HIV and Aging Wksp Read More »
latimes.com HIV-resistant cells work in mice. Can they help humans? California scientists, boosted by stem cell research funding enabled by Proposition 71, are aiming for clinical trials involving gene therapy through bone marrow transplants. By Rachel Bernstein, Los Angeles Times 6:44 PM PDT, August 21, 2010 Clad in a yellow gown, blue foot covers, hair
HIV-resistant cells work in mice. Can they help humans? Read More »
www.hivresearchcatalyst.org/files/user_1/SYT1Vergel.ppt
Nelson’s Lecture on Activism Needs Related to Metabolic Disorders and Aging with HIV Read More »
Nandrolone can do this easily, as long as doctors have a very close monitoring on hematocrit since older men tend to have more problems with polycythemia https://www.nytimes.com/2010/08/31/health/research/31muscle.html?adxnnl=1&adxnnlx=1283259693-/5OVKCtiMHD2uTxULb30yQ
Doctors Seek Way to Treat Muscle Loss Read More »
https://www.businessweek.com/lifestyle/content/healthday/642400.html?chan=rss_topStories_ssi_5 A study published in the Public Library of Science (PLoS) in 2010 concluded that four anti-HIV drugs also inhibit XMRV replication.[33] The drugs were two retroviral integrase inhibitors; raltegravir (Merck & Co., brand name Isentress), L-000870812 (Merck & Co.), and two nucleoside reverse transcriptase inhibitors; tenofovir disoproxil fumarate (Gilead Sciences, brand name Viread), and zidovudine (GlaxoSmithKline, azidothymidine (AZT)). Synergistic effects were reported when
Can HIV medications treat Chronic Fatigue Syndrome? Read More »
Introducción Mi relación con la sustitución hormonal ha sido larga y fructífera. Yo fui diagnosticado con testosterona baja en 1993, a la edad de 34, luego de haber estado viviendo con VIH por 11 años. Yo había perdido 14 libras (6,35 Kg) involuntariamente, me sentía cansado y deprimido, y no tenía deseo sexual en lo
IAC Summary on New Drugs and New Combinations – How will They Change What We Do? Vienna July 18-23 2010 Joe Eron, Univ of North Carolina This year’s IAC was one of the most exciting and data-filled International AIDS meetings since Vancouver in 1996. The defining presentation of the meeting was the CAPRISA 004 study that
New Drugs and New Combinations – How will They Change What We Do? Read More »
This report reviews the status of research of drugs for HIV, TB, Hepatis C, immune based therapies. https://i-base.info/files/2010/06/2010-pipeline-webFINAL.pdf
HIV, TB, Hep C, Immune therapies 2010 Pipeline Report Read More »
What am I going to do now, Nelson? Aug 6, 2010 Hi Nelson, I hope all is well. Last year you told me about the trial with ibalizumab at ACRIA and I received the meds for about 1 year. In the beginning of thet trial the virus became undectadable but then it started to go
What am I going to do now, Nelson? Read More »
